A detailed history of Ziegler Capital Management, LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Ziegler Capital Management, LLC holds 13,898 shares of IDYA stock, worth $520,619. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,898
Previous 12,620 10.13%
Holding current value
$520,619
Previous $449,000 35.63%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$34.2 - $47.13 $43,707 - $60,232
1,278 Added 10.13%
13,898 $609,000
Q4 2023

Jan 11, 2024

SELL
$24.59 - $35.83 $395,702 - $576,576
-16,092 Reduced 56.05%
12,620 $449,000
Q3 2023

Oct 16, 2023

SELL
$21.07 - $29.77 $54,655 - $77,223
-2,594 Reduced 8.29%
28,712 $774,000
Q2 2023

Jul 25, 2023

BUY
$13.33 - $25.53 $63,930 - $122,441
4,796 Added 18.09%
31,306 $735,000
Q1 2023

May 04, 2023

BUY
$13.49 - $18.72 $357,619 - $496,267
26,510 New
26,510 $363,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.8B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.